From: Evolution of patterns of care for women with cervical cancer in Morocco over a decade
Period of diagnosis | Total | ||
---|---|---|---|
2008–2012 | 2013–2017 | n (%) | |
n (%) | n (%) | ||
Patients who received treatment | 472 | 317 | 789 |
Patients who received radiotherapy | 437 (92.6) | 282 (89.0) | 719 (91.1) |
EBRT and brachytherapy | 226 (51.7) | 100 (35.5) | 326 (45.3) |
EBRT alone | 171 (39.1) | 151 (53.5) | 322 (44.8) |
Brachytherapy alone | 35 (8.0) | 24 (8.5) | 59 (8.2) |
Unknown | 5 (1.1) | 7 (2.5) | 12 (1.7) |
Patients who received brachytherapy | 261 | 124 | 385 |
Brachytherapy type | |||
Low dose rate | 178 (68.2) | 13 (10.5) | 191 (49.6) |
High dose rate | 83 (31.8) | 111 (89.5) | 194 (50.4) |
Patients who received Concomitant CT-RT (chemoradiation) | 233 (53.3) | 147 (52.1) | 380 (52.9) |
If radiotherapy was received before or after registration at oncology centre | |||
Before | 20 (4.6) | 23 (8.5) | 43 (6.1) |
After | 413 (95.4) | 247 (91.5) | 660 (93.9) |
Missing | 4 (0.9) | 12 (4.3) | 16 (2.2) |
EBRT total | 397 | 251 | 648 |
Duration (weeks) | |||
< 4 | 58 (15.7) | 21 (9.5) | 79 (13.4) |
4–6 | 198 (53.5) | 113 (51.1) | 311 (52.6) |
7–8 | 44 (11.9) | 22 (10.0) | 66 (11.2) |
9 + | 70 (18.9) | 65 (29.4) | 135 (22.8) |
Total duration of radiotherapy (weeks) | |||
< 10 | 137 (85.1) | 48 (61.5) | 185 (77.4) |
10–12 | 9 (5.6) | 10 (12.8) | 19 (7.9) |
13–14 | 7 (4.3) | 7 (9.0) | 14 (5.9) |
15 + | 8 (5.0) | 13 (16.7) | 21 (8.8) |
Hospitalization for radiotherapy | 61 | 9 | 70 |